HEPAR COMPOSITUM
HEPAR COMPOSITUM
Discontinued
DIN Number
02236496
Drug Class
Human
Market Date
Feb 6, 1998
Company
HC
Biologische Heilmittel Heel Gmbh
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02236496
AIG Number1331915001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification
ACTIVE INGREDIENTS (13)
CELANDINEActive
Strength: 4 D
Monograph: CELANDINE
CHOLESTEROLActive
Strength: 10 D
Monograph: CHOLESTEROL
CINCHONA OFFICINALISActive
Strength: 4 D
Monograph: CINCHONA OFFICINALIS
CYNARA SCOLYMUSActive
Strength: 6 D
Monograph: CYNARA SCOLYMUS
HISTAMINE DIHYDROCHLORIDEActive
Strength: 10 D
Monograph: HISTAMINE DIHYDROCHLORIDE
LYCOPODIUM CLAVATUMActive
Strength: 4 D
Monograph: LYCOPODIUM CLAVATUM
MILK THISTLEActive
Strength: 3 D
Monograph: MILK THISTLE
NADIDUMActive
Strength: 12 D
Monograph: NADIDUM
OATSActive
Strength: 6 D
Monograph: OATS
OYSTER SHELLSActive
Strength: 28 D
Monograph: OYSTER SHELLS
SULFURActive
Strength: 13 D
Monograph: SULFUR
TARAXACUM OFFICINALE WEBERActive
Strength: 4 D
Monograph: TARAXACUM OFFICINALE WEBER
THIOCTIC ACIDActive
Strength: 12 D
Monograph: THIOCTIC ACID